CFM
BLTE

Capricorn Fund Managers’s Belite Bio BLTE Stock Holding History

Capricorn Fund Managers’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$986K Buy
+6,400
New +$981K 0.08% 142

Other funds holding BLTE

HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Capricorn Fund Managers's BLTE Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Belite Bio (BLTE) in Q2 2026: 6,400 shares worth $986K. The stake represents 0.08% of the portfolio and ranks #142 among its holdings.

10 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Capricorn Fund Managers held 6,400 shares of Belite Bio worth $986K as of Q2 2026.
  • Belite Bio was a new Capricorn Fund Managers position in Q2 2026.
  • Belite Bio made up 0.08% of Capricorn Fund Managers's portfolio in Q2 2026, its #142 holding.
  • 10 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.